SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stan Graaf, Ulrich Beuers, Autophagy – another piece of the puzzle towards understanding primary biliary cirrhosis?, Liver International, 2014, 34, 4
  2. 2
    Negin Karimian, Andrie C. Westerkamp, Robert J. Porte, Biliary complications after orthotopic liver transplantation, Current Opinion in Organ Transplantation, 2014, 19, 3, 209

    CrossRef

  3. 3
    Marion J. Pollheimer, Peter Fickert, Bruno Stieger, Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis, Molecular Aspects of Medicine, 2014, 37, 35

    CrossRef

  4. 4
    Luca Maroni, Stan F. J. van de Graaf, Simon D. Hohenester, Ronald P. J. Oude Elferink, Ulrich Beuers, Fucosyltransferase 2: A Genetic Risk Factor for Primary Sclerosing Cholangitis and Crohn's Disease—A Comprehensive Review, Clinical Reviews in Allergy & Immunology, 2014,

    CrossRef

  5. 5
    Ralf Kubitz, Carola Dröge, Stefanie Kluge, Jan Stindt, Dieter Häussinger, Genetic variations of bile salt transporters, Drug Discovery Today: Technologies, 2014, 12, e55

    CrossRef

  6. 6
    Kerem Sebib Korkmaz, Bert-Jan F. Rooij, Bart Hoek, Marcel Janse, Minneke J. Coenraad, Johan J. Reijden, Rinse K. Weersma, Robert J. Porte, Philip W. Voorneveld, Andrzej G. Baranski, Hein W. Verspaget, MMP-2 is a disease-modifying gene in primary sclerosing cholangitis, Liver International, 2014, 34, 2
  7. 7
    Simon Hohenester, Timo Vennegeerts, Michaela Wagner, Ralf Wimmer, Heidrun Drolle, Christina Rieger, Gerald U. Denk, Christian Rust, Michael Fiegl, Physiological hypoxia prevents bile salt-induced apoptosis in human and rat hepatocytes, Liver International, 2014, 34, 6
  8. 8
    T. H. Karlsen, M. Vesterhus, K. M. Boberg, Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 3
  9. 9
    Vincent Zimmer, Frank Lammert, Role of genetics in diagnosis and therapy of acquired liver disease, Molecular Aspects of Medicine, 2014, 37, 15

    CrossRef

  10. 10
    Shannon Glaser, Fanyin Meng, Yuyan Han, Paolo Onori, Billy K. Chow, Heather Francis, Julie Venter, Kelly McDaniel, Marco Marzioni, Pietro Invernizzi, Yoshiyuki Ueno, Jia-ming Lai, Li Huang, Holly Standeford, Domenico Alvaro, Eugenio Gaudio, Antonio Franchitto, Gianfranco Alpini, Secretin Stimulates Biliary Cell Proliferation by Regulating Expression of MicroRNA 125b and MicroRNA let7a in Mice, Gastroenterology, 2014, 146, 7, 1795

    CrossRef

  11. 11
    Neil D. Young, Niranjan Nagarajan, Suling Joyce Lin, Pasi K. Korhonen, Aaron R. Jex, Ross S. Hall, Helena Safavi-Hemami, Worasak Kaewkong, Denis Bertrand, Song Gao, Qihui Seet, Sopit Wongkham, Bin Tean Teh, Chaisiri Wongkham, Pewpan Maleewong Intapan, Wanchai Maleewong, Xinhua Yang, Min Hu, Zuo Wang, Andreas Hofmann, Paul W. Sternberg, Patrick Tan, Jun Wang, Robin B. Gasser, The Opisthorchis viverrini genome provides insights into life in the bile duct, Nature Communications, 2014, 5,

    CrossRef

  12. 12
    Adrianne F. Pike, Nynke I. Kramer, Bas J. Blaauboer, Willem Seinen, Ruud Brands, A novel hypothesis for an alkaline phosphatase ‘rescue’ mechanism in the hepatic acute phase immune response, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 12, 2044

    CrossRef

  13. 13
    Frank G. Schaap, Michael Trauner, Peter L. M. Jansen, Bile acid receptors as targets for drug development, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 1, 55

    CrossRef

  14. 14
    Christoph Jüngst, Thomas Berg, Jun Cheng, Richard M. Green, Jidong Jia, Andrew L. Mason, Frank Lammert, Intrahepatic cholestasis in common chronic liver diseases, European Journal of Clinical Investigation, 2013, 43, 10
  15. 15
    C.M.A. Otte, L.C. Penning, J. Rothuizen, R.P. Favier, Retrospective comparison of prednisolone and ursodeoxycholic acid for the treatment of feline lymphocytic cholangitis, The Veterinary Journal, 2013, 195, 2, 205

    CrossRef

  16. 16
    Verena Keitel, Dieter Häussinger, TGR5 in cholangiocytes, Current Opinion in Gastroenterology, 2013, 29, 3, 299

    CrossRef

  17. 17
    Gideon M. Hirschfield, M. Eric Gershwin, The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis, Annual Review of Pathology: Mechanisms of Disease, 2013, 8, 1, 303

    CrossRef

  18. 18
    Tom H. Karlsen, Kirsten Muri Boberg, Update on primary sclerosing cholangitis, Journal of Hepatology, 2013, 59, 3, 571

    CrossRef

  19. 19
    Hanns–Ulrich Marschall, Ulrich Beuers, When Bile Acids Don't Get Amidated, Gastroenterology, 2013, 144, 5, 870

    CrossRef

  20. 20
    Simon Hohenester, Lucas Maillette de Buy Wenniger, Coen C. Paulusma, Sandra J. van Vliet, Douglas M. Jefferson, Ronald P. Oude Elferink, Ulrich Beuers, A biliary HCO3 umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes, Hepatology, 2012, 55, 1
  21. 21
    James L. Boyer, Carol J. Soroka, A Cholecystohepatic Shunt Pathway: Does the Gallbladder Protect the Liver?, Gastroenterology, 2012, 142, 7, 1416

    CrossRef

  22. 22
    Serge Erlinger, A HCO3-umbrella protects human cholangiocytes against bile salt-induced injury, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 1, 7

    CrossRef

  23. 23
    Axel R. Concepcion, Juan F. Medina, Approaches to the pathogenesis of primary biliary cirrhosis through animal models, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 1, 21

    CrossRef

  24. 24
    Jörg König, Sabine Klatt, Karin Dilger, Martin F. Fromm, Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters OATP1B1, OATP1B3, OATP2B1 and NTCP, Basic & Clinical Pharmacology & Toxicology, 2012, 111, 2
  25. 25
    Dominique Debray, Dominique Rainteau, Véronique Barbu, Myriam Rouahi, Haquima El Mourabit, Stéphanie Lerondel, Colette Rey, Lydie Humbert, Dominique Wendum, Charles–Henry Cottart, Paul Dawson, Nicolas Chignard, Chantal Housset, Defects in Gallbladder Emptying and Bile Acid Homeostasis in Mice With Cystic Fibrosis Transmembrane Conductance Regulator Deficiencies, Gastroenterology, 2012, 142, 7, 1581

    CrossRef

  26. 26
    Karin Dilger, Simon Hohenester, Ursula Winkler-Budenhofer, Barbara A.J. Bastiaansen, Frank G. Schaap, Christian Rust, Ulrich Beuers, Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health, Journal of Hepatology, 2012, 57, 1, 133

    CrossRef

  27. 27
    Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, Andre Franke, Tom H. Karlsen, Genetics in primary sclerosing cholangitis, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 4, 325

    CrossRef

  28. 28
    Raffaele Cursio, Jean Gugenheim, Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation, Journal of Transplantation, 2012, 2012, 1

    CrossRef

  29. 29
    L J Maillette de Buy Wenniger, R P Oude Elferink, U Beuers, Molecular Targets for the Treatment of Fibrosing Cholangiopathies, Clinical Pharmacology & Therapeutics, 2012, 92, 3, 381

    CrossRef

  30. 30
    Olivier Chazouillères, Primary sclerosing cholangitis and bile acids, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, S21

    CrossRef

  31. 31
    Rui E. Castro, Cecília M.P. Rodrigues, Targeting miR-506 in primary biliary cirrhosis to support the HCO3− umbrella, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 5, 402

    CrossRef

  32. 32
    Ulrich Beuers, Luca Maroni, Ronald O. Elferink, The biliary HCO3− umbrella, Current Opinion in Gastroenterology, 2012, 28, 3, 253

    CrossRef

  33. 33
    Dimitrios P. Bogdanos, Daniel S. Smyk, Eirini I. Rigopoulou, Maria G. Mytilinaiou, Michael A. Heneghan, Carlo Selmi, M. Eric Gershwin, Twin studies in autoimmune disease: Genetics, gender and environment, Journal of Autoimmunity, 2012, 38, 2-3, J156

    CrossRef

  34. 34
    Jesús M. Banales, Elena Sáez, Miriam Úriz, Sarai Sarvide, Aura D. Urribarri, Patrick Splinter, Pamela S. Tietz Bogert, Luis Bujanda, Jesús Prieto, Juan F. Medina, Nicholas F. LaRusso, Up-regulation of microRNA 506 leads to decreased Cl/HCO3 anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis, Hepatology, 2012, 56, 2
  35. 35
    Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso, Physiology of the Gastrointestinal Tract, 2012,

    CrossRef

  36. 36
    Ulrich Beuers, Keith D. Lindor, A major step towards effective treatment evaluation in primary biliary cirrhosis, Journal of Hepatology, 2011, 55, 6, 1178

    CrossRef

  37. 37
    Simon Hohenester, Lucas Maillette de Buy Wenniger, Douglas M. Jefferson, Ronald P. Oude Elferink, Ulrich Beuers, Biliary Bicarbonate Secretion Constitutes a Protective Mechanism against Bile Acid- Induced Injury in Man, Digestive Diseases, 2011, 29, 1, 62

    CrossRef

  38. 38
    Serge Erlinger, Chronic fibrosing cholangiopathies: A consequence of a defective HCO3− “umbrella”?, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 2, 85

    CrossRef

  39. 39
    Anna Baghdasaryan, Thierry Claudel, Judith Gumhold, Dagmar Silbert, Luciano Adorini, Aldo Roda, Stefania Vecchiotti, Frank J. Gonzalez, Kristina Schoonjans, Mario Strazzabosco, Peter Fickert, Michael Trauner, Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2−/− (Abcb4−/−) mouse cholangiopathy model by promoting biliary HCOmath image output, Hepatology, 2011, 54, 4
  40. 40
    Vincent Zimmer, Frank Lammert, Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases, Best Practice & Research Clinical Gastroenterology, 2011, 25, 2, 269

    CrossRef

  41. 41
    Vincent Zimmer, Frank Lammert, Genetics in liver disease: new concepts, Current Opinion in Gastroenterology, 2011, 27, 3, 231

    CrossRef

  42. 42
    Trine Folseraas, Espen Melum, Andre Franke, Tom H. Karlsen, Genetics in primary sclerosing cholangitis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 6, 713

    CrossRef

  43. 43
    Sanna op den Dries, Michael E. Sutton, Ton Lisman, Robert J. Porte, Protection of Bile Ducts in Liver Transplantation: Looking Beyond Ischemia, Transplantation, 2011, 92, 4, 373

    CrossRef

  44. 44
    Juan F. Medina, Role of the Anion Exchanger 2 in the Pathogenesis and Treatment of Primary Biliary Cirrhosis, Digestive Diseases, 2011, 29, 1, 103

    CrossRef

  45. 45
    Johannes R. Hov, Verena Keitel, Erik Schrumpf, Dieter Häussinger, Tom H. Karlsen, TGR5 Sequence Variation in Primary Sclerosing Cholangitis, Digestive Diseases, 2011, 29, 1, 78

    CrossRef

  46. 46
    Gideon M. Hirschfield, E. Jenny Heathcote, M. Eric Gershwin, Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches, Gastroenterology, 2010, 139, 5, 1481

    CrossRef

  47. 47
    James H. Tabibian, Anatoliy I. Masyuk, Tetyana V. Masyuk, Steven P. O'Hara, Nicholas F. LaRusso, Physiology of Cholangiocytes, Comprehensive Physiology,